TABLE 1 MAJOR TAVI APPROVED DEVICES
TABLE 2 CLINICAL TRIALS, TAVI MARKET, 20122016
TABLE 3 WORLD TAVI MARKET, BY PROCEDURE, 20142022 ($MILLION)
TABLE 4 WORLD TAVI MARKET, BY PROCEDURE, 20142022 (UNITS)
TABLE 5 WORLD TAVI MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 6 WORLD TAVI MARKET, BY GEOGRAPHY, 20142022 (UNITS)
TABLE 7 NORTH AMERICA TAVI MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 8 NORTH AMERICA TAVI MARKET, BY COUNTRY, 20142022 (UNITS)
TABLE 9 NORTH AMERICA TAVI MARKET, BY PROCEDURE, 20142022 ($MILLION)
TABLE 10 NORTH AMERICA TAVI MARKET, BY PROCEDURE, 20142022 (UNITS)
TABLE 11 EUROPE: TAVI MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 12 EUROPE: TAVI MARKET, BY COUNTRY, 20142022 (UNITS)
TABLE 13 EUROPE: TAVI MARKET, BY PROCEDURE, 2014-2022 ($MILLION)
TABLE 14 EUROPE: TAVI MARKET, BY PROCEDURE, 2014-2022 (UNITS)
TABLE 15 ASIA-PACIFIC: TAVI MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 16 ASIA-PACIFIC: TAVI MARKET, BY COUNTRY, 20142022 (UNITS)
TABLE 17 ASIA-PACIFIC: TAVI MARKET, BY PROCEDURE, 20142022 ($MILLION)
TABLE 18 ASIA-PACIFIC: TAVI MARKET, BY PROCEDURE, 20142022 (UNITS)
TABLE 19 LAMEA: TAVI MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 20 LAMEA: TAVI MARKET, BY COUNTRY, 20142022 (UNITS)
TABLE 21 LAMEA: TAVI MARKET, BY PROCEDURE, 20142022 ($MILLION)
TABLE 22 LAMEA: TAVI MARKET, BY PROCEDURE, 20142022 (UNITS)
TABLE 23 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 24 BOSTON SCIENTIFIC: PRODUCT CATEGORIES
TABLE 25 DIRECT FLOW MEDICAL: COMPANY SNAPSHOT
TABLE 26 EDWARDS LIFESCIENCES: COMPANY SNAPSHOT
TABLE 27 EDWARDS LIFESCIENCES: PRODUCT CATEGORIES
TABLE 28 JENAVALVE-COMPANY SNAPSHOT
TABLE 29 MEDTRONIC-COMPANY SNAPSHOT
TABLE 30 MEDTRONIC: PRODUCT CATEGORIES
TABLE 31 MERIL LIFE SCIENCES: COMPANY SNAPSHOT
TABLE 32 MERIL LIFE SCIENCES: PRODUCT CATEGORIES
TABLE 33 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 34 ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 35 SYMETIS: COMPANY SNAPSHOT
TABLE 36 TRANSCATHETER TECHNOLOGIES -COMPANY SNAPSHOT

LIST OF FIGURE

FIG. 1 PORTERS FIVE FORCES ANALYSIS
FIG. 2 MARKET SHARE ANALYSIS, 2015
FIG. 3 TOP IMPACTING FACTORS: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, 2014-2022
FIG. 4 AGE DISTRIBUTION OF TAVR PATIENTS, U.S., 2013
FIG. 5 U.S. TAVI MARKET, (20142022) ($MILLION)
FIG. 6 CANADA TAVI MARKET, (20142022) ($MILLION)
FIG. 7 MEXICO TAVI MARKET, (20142022) ($MILLION)
FIG. 8 GERMANY TAVI MARKET, (20142022) ($MILLION)
FIG. 9 FRANCE TAVI MARKET, (20142022) ($MILLION)
FIG. 10 U.K. TAVI MARKET, (20142022) ($MILLION)
FIG. 11 ITALY TAVI MARKET, (20142022) ($MILLION)
FIG. 12 SWITZERLAND TAVI MARKET, (20142022) ($MILLION)
FIG. 13 REST OF EUROPE TAVI MARKET, (20142022) ($MILLION)
FIG. 14 INDIA TAVI MARKET, (20142022) ($MILLION)
FIG. 15 CHINA TAVI MARKET, (20142022) ($MILLION)
FIG. 16 JAPAN TAVI MARKET, (20142022) ($MILLION)
FIG. 17 AUSTRALIA TAVI MARKET, (20142022) ($MILLION)
FIG. 18 SOUTH KOREA TAVI MARKET, (20142022) ($MILLION)
FIG. 19 REST OF ASIA-PACIFIC TAVI MARKET, (20142022) ($MILLION)
FIG. 20 LATIN AMERICA TAVI MARKET, (20142022) ($MILLION)
FIG. 21 ISRAEL TAVI MARKET, (20142022) ($MILLION)
FIG. 22 SAUDI ARABIA TAVI MARKET, (20142022) ($MILLION)
FIG. 23 SOUTH AFRICA TAVI MARKET, (20142022) ($MILLION)
FIG. 24 REST OF LAMEA TAVI MARKET, (20152022) ($MILLION)
FIG. 25 BOSTON SCIENTIFIC: NET SALES, 20132015 ($MILLION)
FIG. 26 BOSTON SCIENTIFIC: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 27 BOSTON SCIENTIFIC: CARDIOVASCULAR REVENUE, BY SUBSEGMENT, 2015 (%)
FIG. 28 BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 29 EDWARDS LIFESCIENCES: NET SALES, 20132015 ($MILLION)
FIG. 30 EDWARDS LIFESCIENCES: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 31 EDWARDS LIFESCIENCES: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 32 MEDTRONIC: NET SALES, 20142016 ($MILLION)
FIG. 33 MEDTRONIC: REVENUE, BY SEGMENT, 2016 (%)
FIG. 34 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2016 (%)
FIG. 35 MEDTRONIC: REVENUE, BY GEOGRAPHY, 2016 (%)
FIG. 36 ST. JUDE MEDICAL: NET SALES, 20132015, ($MILLION)
FIG. 37 ST. JUDE MEDICAL: REVENUE BY PRODUCT CATEGORIES, 2015 (%)
FIG. 38 ST. JUDE MEDICAL: REVENUE BY GEOGRAPHY, 2015 (%)